Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine.
De Paolis E, Paris I, Tilocca B, Roncada P, Foca L, Tiberi G, D'Angelo T, Pavese F, Muratore M, Carbognin L, Garganese G, Masetti R, Di Leone A, Fabi A, Scambia G, Urbani A, Generali D, Minucci A, Santonocito C.
De Paolis E, et al. Among authors: roncada p.
Front Oncol. 2023 Jan 18;12:1053035. doi: 10.3389/fonc.2022.1053035. eCollection 2022.
Front Oncol. 2023.
PMID: 36741700
Free PMC article.